Literature DB >> 29800937

Association Between Psychosis in Elderly Patients With Alzheimer Disease and Impaired Social Cognition.

Jeremy Koppel1, Amber Sousa1, Marc L Gordon1, Luca Giliberto1, Erica Christen1, Peter Davies1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29800937      PMCID： PMC6584273          DOI： 10.1001/jamapsychiatry.2018.0482

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  6 in total

1.  The NIMH Research Domain Criteria (RDoC) Project: precision medicine for psychiatry.

Authors:  Thomas R Insel
Journal:  Am J Psychiatry       Date:  2014-04       Impact factor: 18.112

2.  Investigating facial affect processing in psychosis: a study using the Comprehensive Affective Testing System.

Authors:  Susan L Rossell; Tamsyn E Van Rheenen; Nicole R Joshua; Alison O'Regan; Andrea Gogos
Journal:  Schizophr Res       Date:  2014-06-09       Impact factor: 4.939

3.  The recognition of facial expressions of emotion in Alzheimer's disease: a review of findings.

Authors:  Tracey McLellan; Lucy Johnston; John Dalrymple-Alford; Richard Porter
Journal:  Acta Neuropsychiatr       Date:  2008-10       Impact factor: 3.403

4.  Facial emotion perception in schizophrenia: a meta-analytic review.

Authors:  Christian G Kohler; Jeffrey B Walker; Elizabeth A Martin; Kristin M Healey; Paul J Moberg
Journal:  Schizophr Bull       Date:  2009-03-27       Impact factor: 9.306

Review 5.  Social cognition as an RDoC domain.

Authors:  Ruben C Gur; Raquel E Gur
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-11-26       Impact factor: 3.568

Review 6.  Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.

Authors:  Jeremy Koppel; Blaine S Greenwald
Journal:  Neuropsychiatr Dis Treat       Date:  2014-11-24       Impact factor: 2.570
  6 in total
  6 in total

1.  Increased tau phosphorylation follows impeded dopamine clearance in a P301L and novel P301L/COMT-deleted (DM) tau mouse model.

Authors:  Jeremy Koppel; Heidy Jimenez; Leslie Adrien; Eric H Chang; Anil K Malhotra; Peter Davies
Journal:  J Neurochem       Date:  2018-11-12       Impact factor: 5.372

Review 2.  Animal Models of Psychosis in Alzheimer Disease.

Authors:  Josh M Krivinko; Jeremy Koppel; Alena Savonenko; Robert A Sweet
Journal:  Am J Geriatr Psychiatry       Date:  2019-05-17       Impact factor: 4.105

3.  The association of neuropsychiatric symptoms with regional brain volumes from patients in a tertiary multi-disciplinary memory clinic.

Authors:  Milap A Nowrangi; Christopher Marano; Kenichi Oishi; Susumu Mori; Haris I Sair; John Outen; Jeannie Leoutsakos; Constantine Lyketsos; Paul B Rosenberg
Journal:  Int Psychogeriatr       Date:  2020-02-28       Impact factor: 3.878

4.  Greater effect of polygenic risk score for Alzheimer's disease among younger cases who are apolipoprotein E-ε4 carriers.

Authors:  Brian Fulton-Howard; Alison M Goate; Robert P Adelson; Jeremy Koppel; Marc L Gordon; Nir Barzilai; Gil Atzmon; Peter Davies; Yun Freudenberg-Hua
Journal:  Neurobiol Aging       Date:  2020-09-30       Impact factor: 4.673

5.  Increased retention of tau PET ligand [18F]-AV1451 in Alzheimer's Disease Psychosis.

Authors:  J J Gomar; G Tan; J Halpern; M L Gordon; B Greenwald; J Koppel
Journal:  Transl Psychiatry       Date:  2022-02-26       Impact factor: 6.222

Review 6.  A review of the mechanisms underlying selected comorbidities in Alzheimer's disease.

Authors:  Karolina Maciejewska; Kamila Czarnecka; Paweł Szymański
Journal:  Pharmacol Rep       Date:  2021-06-13       Impact factor: 3.024
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.